Evidence map›Paper›PMID 33957900›Full record

ArticleBMC health services research2021

Description of pharmacists' reported interventions to prevent prescribing errors among in hospital inpatients: a cross sectional retrospective study.

Abdulhakim A Alzahrani, Monira M Alwhaibi, Yousif A Asiri, Khalid M Kamal, Tariq M Alhawassi

Open access · goldAbstract read
In one paragraph

Article in BMC health services research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Drug-related problems and their predictors in pediatric community-acquired infections: the role of pharmacist-led interventions in Pakistan.Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Analysis of clinical pharmacists' interventions in a rehabilitation setting.Journal of pharmaceutical policy and practice · 2025
    Article
  9. Article
  10. Methicillin-resistantQatar medical journal · 2024
    Article
  11. Pharmacists' interventions on prescribing errors in Malaysia.Journal of pharmaceutical policy and practice · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Abdulhakim A AlzahraniCollege of Pharmacy, Riyadh Elm University, Riyadh, Saudi Arabia.
Monira M AlwhaibiDepartment of Clinical Pharmacy, College of Pharmacy, King Saud University, PO Box 2457, Office (1A229), 11451, Riyadh, Saudi Arabia.
Yousif A AsiriCollege of Pharmacy, Riyadh Elm University, Riyadh, Saudi Arabia.
Khalid M KamalDivision of Pharmaceutical, Social and Administrative Sciences, School of Pharmacy, Duquesne University, 600 Forbes Avenue, PA, 15282, Pittsburgh, USA.
Tariq M AlhawassiDepartment of Clinical Pharmacy, College of Pharmacy, King Saud University, PO Box 2457, Office (1A229), 11451, Riyadh, Saudi Arabia. tarriq@ksu.edu.sa.
King Saud University · SADuquesne University · USKing Fahad Hospital Jeddah · SARiyadh Elm University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrescribing errors (PEs) are a common cause of morbidity and mortality, both in community practice and in hospitals. Pharmacists have an essential role in minimizing and preventing PEs, thus, there is a need to document the nature of pharmacists' interventions to prevent PEs. The purpose of this study was to describe reported interventions conducted by pharmacists to prevent or minimize PEs in a tertiary care hospital.

methodsA retrospective analysis of the electronic medical records data was conducted to identify pharmacists' interventions related to reported PEs. The PE-related data was extracted for a period of six-month (April to September 2017) and comprised of patient demographics, medication-related information, and the different interventions conducted by the pharmacists. The study was carried in a tertiary care hospital in Riyadh region. The study was ethically reviewed and approved by the hospital IRB committee. Descriptive analyses were appropriately conducted using the IBM SPSS Statistics.

resultsA total of 2,564 pharmacists' interventions related to PEs were recorded. These interventions were reported in 1,565 patients. Wrong dose (54.3 %) and unauthorized prescription (21.9 %) were the most commonly encountered PEs. Anti-infectives for systemic use (49.2 %) and alimentary tract and metabolism medications (18.2 %) were the most common classes involved with PEs. The most commonly reported pharmacists' interventions were dose adjustments (44.0 %), restricted medication approvals (21.9 %), and therapeutic duplications (11 %).

conclusionsIn this study, PEs occurred commonly and pharmacists' interventions were critical in preventing possible medication related harm to patients. Care coordination and prioritizing patient safety through quality improvement initiatives at all levels of the health care system can play a key role in this quality improvement drive. Future studies should evaluate the impact of pharmacists' interventions on patient outcomes.

Indexed as

PharmacistsPharmacy Service, HospitalCross-Sectional StudiesHospitalsHumansInpatientsMedication ErrorsProfessional RoleRetrospective StudiesAcute care settingPatient safetyPharmacists related interventionsPrescribing errors

Identifiers

PMID33957900
PMCPMC8101218
OpenAlexW3113466135

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.